Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
EV to Sales History
Trending higher, below historical average, slight contraction.
Left:
||||
Enterprise value to sales ratio
Latest
2.96
↓ 24% below average
Average (9y)
3.89
Historical baseline
Range
High:6.45
Low:2.54
CAGR
-3.4%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 2.96 | +16.3% |
| 2023 | 2.54 | -25.1% |
| 2022 | 3.40 | +11.1% |
| 2021 | 3.06 | +9.7% |
| 2020 | 2.79 | -24.0% |
| 2019 | 3.67 | -19.6% |
| 2018 | 4.56 | -29.3% |
| 2017 | 6.45 | +19.2% |
| 2016 | 5.41 | +34.0% |
| 2015 | 4.04 | - |